Metropolitan Life Insurance Company (MetLife)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,761
| Closed | -$208K | – | 2390 |
|
|
2022
Q2 | $208K | Sell |
2,761
-224
| -8% | -$16.9K | 0.01% | 680 |
|
|
2022
Q1 | $80.1K | Sell |
2,985
-9,050
| -75% | -$243K | ﹤0.01% | 1344 |
|
|
2021
Q4 | $574K | Hold |
12,035
| – | – | 0.01% | 1328 |
|
|
2021
Q3 | $799K | Sell |
12,035
-589
| -5% | -$39.1K | 0.01% | 1128 |
|
|
2021
Q2 | $985K | Buy |
12,624
+2,521
| +25% | +$197K | 0.01% | 1019 |
|
|
2021
Q1 | $956K | Sell |
10,103
-376
| -4% | -$35.6K | 0.01% | 959 |
|
|
2020
Q4 | $1.28M | Buy |
10,479
+591
| +6% | +$72K | 0.02% | 729 |
|
|
2020
Q3 | $864K | Buy |
9,888
+1,213
| +14% | +$106K | 0.01% | 829 |
|
|
2020
Q2 | $560K | Sell |
8,675
-227
| -3% | -$14.7K | 0.01% | 1120 |
|
|
2020
Q1 | $398K | Buy |
8,902
+239
| +3% | +$10.7K | 0.01% | 1186 |
|
|
2019
Q4 | $540K | Buy |
8,663
+5,482
| +172% | +$341K | 0.01% | 1276 |
|
|
2019
Q3 | $120K | Buy |
3,181
+2,487
| +358% | +$93.5K | ﹤0.01% | 2203 |
|
|
2019
Q2 | $28.2K | Buy |
+694
| New | +$28.2K | ﹤0.01% | 2558 |
|